Diagnostic Microbiology & Infectious Disease
Volume 45, Issue 1 , Pages 45-52 , January 2003

Igm recognition of recombinant Toxoplasma gondii antigens by sera of acutely or latently infected humans

  • Bob Meek

      Affiliations

    • Department of Molecular Immunology, the Netherlands Ophthalmic Research Institute, Amsterdam, The Netherlands
  • ,
  • Robert Jan Diepersloot

      Affiliations

    • Laboratory for Medical Microbiology, Diakonessen Hospital, Utrecht, The Netherlands
  • ,
  • Tom van Gool

      Affiliations

    • Department of Medical Microbiology, Section Parasitology, Academic Medical Center, Amsterdam, The Netherlands
  • ,
  • Dave Speijer

      Affiliations

    • Department of Biochemistry, University of Amsterdam, Amsterdam, The Netherlands
  • ,
  • Ron Peek

      Affiliations

    • Department of Molecular Immunology, the Netherlands Ophthalmic Research Institute, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31-20-5666101; fax: +31-20-5666121.

Received 29 April 2002 ,Accepted 19 August 2002.

References 

  1. Aubert D, Maine GT, Villena I, Hunt JC, Howard L, Sheu M, et al. Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol. 2000;38:1144–1150
  2. Beaman MH, McCabe RE, Wong SY, Remington JS. Toxoplasma gondii. In:  Mandell GL,  Bennett JE,  Dolin R editor. Mandell, Douglas and Bennett’s principles and practice of infectious diseases. New York: Churchill Livingstone Inc; 1995;p. 2455–2475
  3. Biemans R, Gregoire D, Haumont M, Bosseloir A, Garcia L, Jacquet A, et al. The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation. J Biotechn. 1998;66:137–146
  4. Bobic B, Sibalic D, Djurkovic-Djakovic O. High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary toxoplasma infection. Case report. Gynecol Obstet Invest. 1991;31:182–184
  5. Carruthers VB, Sibley LD. Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. Eur J Cell Biol. 1997;73:114–123
  6. Cesbron JY, Capron A, Ovlaque G, Santoro F. Use of a monoclonal antibody in a double-sandwich ELISA for detection of IgM antibodies to Toxoplasma gondii major surface protein (P30). J Immunol Methods. 1985;83:151–158
  7. Couvreur G, Sadak A, Fortier B, Dubremetz JF. Surface antigens of Toxoplasma gondii. Parasitology. 1988;97:1–10
  8. Del Bono V, Canessa A, Bruzzi P, Fiorelli MA, Terragna A. Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J Clin Microbiol. 1989;27:2133–2135
  9. Erlich HA, Rodgers G, Vaillancourt P, Araujo FG, Remington JS. Identification of an antigen-specific immunoglobulin M antibody associated with acute Toxoplasma infection. Infect Immun. 1983;41:683–690
  10. Gorgievski-Hrisoho M, Germann D, Matter L. Diagnostic implications of kinetics of immunoglobulin M and A antibody responses to Toxoplasma gondii. J Clin Microbiol. 1996;34:1506–1511
  11. Harning D, Spenter J, Metsis A, Vuust J, Petersen E. Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin Diagn Lab Immunol. 1996;3:355–357
  12. Klaren VN, Peek R. Evidence for a compartmentalized B cell response as characterized by IgG epitope specificity in human ocular toxoplasmosis. J Immunol. 2001;167:6263–6269
  13. Leriche MA, Dubremetz JF. Characterization of the protein contents of rhoptries and dense granules of Toxoplasma gondii tachyzoites by subcellular fractionation and monoclonal antibodies. Mol Biochem Parasitol. 1991;45:249–259
  14. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing (the Platelia Toxo IgM test). J Clin Microbiol. 1997;35:174–178
  15. Manger ID, Hehl AB, Boothroyd JC. The surface of Toxoplasma tachyzoites is dominated by a family of glycosylphosphatidylinositol-anchored antigens related to SAG1. Infect Immun. 1998;66:2237–2244
  16. Meek B, Klaren VN, van Haeringen NJ, Kijlstra A, Peek R. IgA antibodies to Toxoplasma gondii in human tears. Invest Ophthalmol Vis Sc. 2000;41:2584–2590
  17. Meek B, van Gool T, Gilis H, Peek R. Dissecting the IgM antibody response during the acute and latent phase of toxoplasmosis. Diagn Microbiol Infect Dis. 2001;41:131–137
  18. Nagel SD, Boothroyd JC. The major surface antigen, P30, of Toxoplasma gondii is anchored by a glycolipid. J Biol Chem. 1989;264:5569–5574
  19. Ortega-Barria E, Boothroyd JC. A Toxoplasma lectin-like activity specific for sulfated polysaccharides is involved in host cell infection. J Biol Chem. 1999;274:1267–1276
  20. Ossorio PN, Schwartzman JD, Boothroyd JC. A Toxoplasma gondii rhoptry protein associated with host cell penetration has unusual charge asymmetry. Mol Biochem Parasitol. 1992;50:1–15
  21. Pekari K, Tailler D, Weingart R, Schmidt RR. Synthesis of the fully phosphorylated GPI anchor pseudohexasaccharide of Toxoplasma gondii. J Org Chem. 2001;66:7432–7442
  22. Saffer LD, Mercereau-Puijalon O, Dubremetz JF, Schwartzman JD. Localization of a Toxoplasma gondii rhoptry protein by immunoelectron microscopy during and after host cell penetration. J Protozool. 1992;39:526–530
  23. Schagger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987;166:368–379
  24. Schwartzman JD. Inhibition of a penetration-enhancing factor of Toxoplasma gondii by monoclonal antibodies specific for rhoptries. Infect Immun. 1986;51:760–764
  25. Sharma SD, Mullenax J, Araujo FG, Erlich HA, Remington JS. Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol. 1983;131:977–983
  26. Suzuki Y, Ramirez R, Press C, Li S, Parmley S, Thulliez P, et al. Detection of immunoglobulin M antibodies to P35 antigen of Toxoplasma gondii for serodiagnosis of recently acquired infection in pregnant women. J Clin Microbiol. 2000;38:3967–3970
  27. Tomavo S, Couvreur G, Leriche MA, Sadak A, Achbarou A, Fortier B, et al. Immunolocalization and characterization of the low molecular weight antigen (4-5 kDa) of Toxoplasma gondii that elicits an early IgM response upon primary infection. Parasitology. 1994;108:139–145
  28. Tomavo S, Schwarz RT, Dubremetz JF. Evidence for glycosyl-phosphatidylinositol anchoring of Toxoplasma gondii major surface antigens. Mol Cell Biol. 1989;9:4576–4580
  29. Velge-Roussel F, Chardes T, Mevelec P, Brillard M, Hoebeke J, Bout D. Epitopic analysis of the Toxoplasma gondii major surface antigen SAG1. Mol Biochem Parasitol. 1994;66:31–38
  30. Verhofstede C, Van Renterghem L, Plum J. Evaluation of immunoblotting for the detection of Toxoplasma gondii immunoglobulin M antibodies. Eur J Clin Microbiol Infect Dis. 1990;9:835–837
  31. Zinecker CF, Striepen B, Geyer H, Geyer R, Dubremetz JF, Schwarz RT. Two glycoforms are present in the GPI-membrane anchor of the surface antigen 1 (P30) of Toxoplasma gondii. Mol Biochem Parasitol. 2001;116:127–135

PII: S0732-8893(02)00476-5

doi: 10.1016/S0732-8893(02)00476-5

Diagnostic Microbiology & Infectious Disease
Volume 45, Issue 1 , Pages 45-52 , January 2003